Objectives: Novel chemical tools to eliminate malaria should ideally target both the asexual parasites and transmissible gametocytes. Several imidazopyridazines (IMPs) and 2-aminopyridines (2-APs) have been described as potent antimalarial candidates targeting lipid kinases. However, these have not been extensively explored for stage-specific inhibition of gametocytes in Plasmodium falciparum parasites. Here we provide an indepth evaluation of the gametocytocidal activity of compounds from these chemotypes and identify novel starting points for dual-acting antimalarials.
Introduction
Most antimalarial drugs targeting the asexual blood stages of the most lethal malaria parasite, Plasmodium falciparum, are not clinically useful against the transmissible, sexual gametocyte forms. 1, 2 Robust in vitro gametocyte production and screening platforms [3] [4] [5] have allowed evaluation of compound libraries to target P. falciparum gametocytes [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] and identify compounds with dual activity against both asexual parasites and gametocytes [17] [18] [19] or, alternatively, with strategy-specific abilities, targeting either asexual parasites or gametocytes. 18, 19 An image-based (fluorescence-based confocal imaging of DAPIstained parasites) high-throughput screen of 36 608 compounds of the BioFocus V R DPI SoftFocus V R library revealed 222 selective hits against P. falciparum parasites. 20 These provided high-quality starting points with potent activity against P. falciparum asexual blood-stages and physicochemical characteristics representative of 'druggable' compounds. 21 Three lead scaffolds, including two kinase-focused inhibitor series, 2-aminopyridines (2-APs) and imidazopyridazines (IMPs), and an ion-channel-focused series of diaminothienyl-pyrimidine (DTP) compounds were used in hit-tolead and lead optimization programmes to identify several lead compounds for the IMPs, 5, 22, 23 DTPs 22,24,25 and 2-APs. [25] [26] [27] [28] This included MMV390048, a phosphatidyl-inositol-4-kinase (PfPI4K) inhibitor currently in clinical trials. 29 Based on the success of the above-mentioned compounds against asexual blood-stage malaria parasites and proof that at least two of them additionally have gametocytocidal activities, 29, 30 representative compounds from the 2-AP, IMP and DTP series were further interrogated here for their gametocytocidal activity. Several 2-APs and IMPs were active against both asexual and gametocyte stages and were profiled through sequential and increasingly more demanding chemical and biological filters, to identify potent chemical scaffolds, useful as dual active antimalarial agents.
Materials and methods

Chemistry
Aminopyridine and aminopyrazine (APs) derivatives were prepared from commercially available 2-amino-5-bromopyridine and 2-aminopyrazines, respectively, as described. [26] [27] [28] 30 The IMPs were synthesized from 3-amino-6-chloropyridazine. 23, 31 Likewise, the DTPs were synthesized as reported. 22, 24 Ethics All in vitro parasite and blood collection work has ethics approvals (University of Pretoria 120821-077; CSIR Ref 10/2011 ; University of the Witwatersrand M130569).
In vitro cultivation of asexual stage parasites and induction of gametocytes P. falciparum asexual cultures were maintained as described before, 32, 33 including the initiation, induction and maintenance of gametocyte cultures from reference strains (drug susceptible NF54).
In vitro P. falciparum antiplasmodial activity and cytotoxicity evaluation
Compounds were screened against P. falciparum K1 (chloroquine, mefloquine and pyrimethamine resistant) and NF54 strains in vitro using a modified [ 3 H]hypoxanthine incorporation assay. 34 In vitro cytotoxicity was determined by screening compounds against Chinese Hamster Ovarian (CHO) cells, using MTT, 35 with emetine as reference. Cells (10 5 cells/mL) were exposed to 10-fold compound serial dilutions for 48 h incubation, in triplicate for two biological replicates. Non-linear dose-response curve fitting analysis allowed IC 50 deduction (GraphPad Prism 6, GraphPad Software Inc.). 36 
In vitro gametocytocidal activity evaluation
Gametocytocidal activity was evaluated independently with a gametocyte-luciferase reporter assay (Luc), an ATP assay or a PrestoBlue V R assay as previously described. 32 All assays were performed in parallel using the same stock of compounds, diluted fresh with glucose-rich complete culture medium from 1 lM stock solutions in DMSO (final DMSO concentration 0.5%). Drug controls included methylene blue (25 lM for the ATP assay, 5 lM for the Luc assay) and MMV390048 (5 lM for the Luc assay). Untreated gametocytes and uninfected erythrocytes/culture medium were used to monitor viability and background, respectively. Primary screen data were analysed using OriginPro 2016 (OriginLab V R Corporation) and quality parameters determined by coefficient of variation (%CV), signal-tobackground ratio (S/B), signal-to-noise ratio (S/N) and Z 0 -factor. IC 50 s were generated with Graphpad Prism 6, represented as means + SEM for n 3 independent biological replicates.
Luciferase reporter assay
A luciferase reporter assay for early (NF54-pfs16-GFP-Luc) and late (NF54-mal8p1.16-GFP-Luc) gametocyte marker cell lines 37 (gift from David Fidock, Columbia University, USA) enabled stage-specific analyses of synchronous gametocyte cultures (2% gametocytaemia, 1.5% haematocrit). Drug assays were performed on early (.90% stage I-III; EG) and late (.95% stage IV/V; LG) gametocytes with 48 h drug pressure as before. 32 
Resazurin-based dye assay
The PrestoBlue V R (Life Technologies) assay was performed on semisynchronous gametocyte cultures (2% gametocytaemia, 5% haematocrit) for 48 h drug pressure on late stage (IV/V; LG) gametocytes. 32 
ATP bioluminescence assay
Late stage gametocytes (.95% stage IV/V) were enriched using density gradient centrifugation and magnetic separation as described. 32 Approximately 50 000 gametocytes were exposed to drug for 24 h.
Characterization, cultivation, genotypic and phenotypic profiling of clinical isolates of southern African origin
Isolates were sampled between February and April 2014 and represent a pool of current southern African parasites (ethics clearance University of Pretoria 417/2013, University of the Witwatersrand M140995). Ex vivo cultures were initiated from intravenous blood samples within 2-24 h, 33 and parasites only maintained for a maximum of five in vitro passages. Cryopreserved stocks were prepared throughout to maintain polyclonal variability for all subsequent gametocyte inductions. All the isolates were phenotyped for drug resistance against artemisinin, chloroquine, dihydroartemisinin (DHA), mefloquine, pyrimethamine and amodiaquine using SYBR Green I fluorescence assays and genotyped using PCR and RFLP for van der Watt et al.
asexual drug resistance markers dhfr (codons 50, 51, 59, 108, 164); dhps (codons 436, 437, 540, 581), pfcrt (codon 76) and pfmdr1 (codon 86). Gametocytogenesis was induced as above and hit compounds evaluated for activity on the resultant late stage (.95% stage IV/V) gametocytes for a panel of nine gametocyte-producing ex vivo African clinical isolates using either the ATP assay (compound evaluated at 1 lM) or with a previously reported parasite lactate dehydrogenase (pLDH) (at 1 % IC 50 of each compound) assay. 38 Gametocytocidal stage-specificity and speed of action Highly synchronized asexual parasites (.97% rings) were used to induce gametocytogenesis to produce compartmentalized early (.90% stage I-III) and late stage gametocytes (.95% stage IV/V) or mature stage V gametocytes (.95% stage V gametocytes). Full dose-response analysis was performed for each compound after 48 h exposure, after which the luciferase activity was measured as described above. To determine speed of action, early and late stage gametocytes were exposed to compounds for 24, 48 and 72 h at IC 50 to allow temporal evaluation of IC 50 fluctuations, ( Figure S1 , available as Supplementary data at JAC Online). All assays were performed on three independent biological replicates (technical triplicates, GraphPad Prism 6).
Standard membrane feeding assay (SMFA)
SMFA was used to determine the infectiousness of gametocytes as previously described. 39 Mature (95% stage V) P. falciparum gametocytes were exposed to various concentrations of MMV642943 (0.001 to 1 lM) for 24 h prior to feeding to Anopheles stephensi mosquitoes. Both exflagellation assay and SMFA were performed as previously described. 40, 41 Physicochemical properties and activity associations Structure-activity landscape index (SALI) and in silico predicted partition coefficient (cLogP, atomic cut-off , 20) or octanol-water distribution coefficient (logD, pH7.4) was performed using OriginPro 2016 and Osiris DataWarrior V 4.2.2 (www.openmolecules.org). Activity cliff analysis was performed with the SkelSpheres descriptor as similarity criterion and takes into account stereochemistry, duplicate fragments and heteroatom depleted skeletons; similarity threshold at 80%.
DNA microarray analysis
Synchronized asexual NF54 parasite cultures (7%-10% parasitaemia, 90 mL) and late stage gametocyte cultures (2%-3% gametocytaemia, stage IV/V, enriched by Nycoprep 1.077 centrifugation) were treated with 10 % IC 50 of MMV390048 or MMV642943 for 24-48 h. DNA microarray was performed on P. falciparum custom Agilent 60-mer 8%15k arrays (AMADID#037237, 42 see Supplementary Methods). The full dataset is available at the Gene Expression Omnibus (GSE100692).
Results
Hit identification
In total, 66 compounds belonging to the 2-AP (31 representatives), IMP (23 representatives), and DTP (12 representatives) series were evaluated for their activity against late stage gametocytes (.95% stage IV/V). All compounds were cross-validated on three independent assay platforms (Luc reporter, ATP and Prestoblue V R assays) to interrogate different biological endpoints and minimize assay interference. Strict selection criteria were imposed requiring primary hits to pass thresholds of .50% (1 lM) and .70% inhibition (5 lM) (Figure 1) . 18 Overall, the 2-APs were the most active compounds, with a hit rate of 84% on the Luc assay ( Figure 2 ). By contrast, the DTPs displayed a 33% hit rate on the ATP assay, whereas very similar hit rates of 30%-70% were observed for the IMPs, irrespective of the assay platform used. A comparison of the compound efficacy across the three assay platforms indicated high similarity (Pearson r 2 " 0.82) between the Luc and ATP assays, whereas the PrestoBlue V R assay showed a strong correlation for the IMPs with one or the other assay platforms (r 2 of 0.82 and 0.74, respectively).
The selected 50 primary hits were evaluated with dose-response to determine their IC 50 values on late stage gametocytes (.95% stage IV/V), which corresponded well to the inhibition data obtained from the primary screen (Table S1 ). Of these, 34 compounds had submicromolar IC 50 s (Figure 3a) , composed of 6% DTPs, 62% 2-APs and 32% IMPs. These compounds also maintained activity on asexual blood-stages ( Figure 3a , Table S1 ), with 14-fold drop in inhibitory activity between asexual parasites and gametocytes. However, the rank order of compounds with activity against asexual parasites and active against gametocytes differed, indicating that preference towards specific gametocyte stages is present even within clusters of compounds with dual gametocyteasexual activity (Table S1 ).
The 12 most potent compounds ( Figure 3b ) on late stage gametocytes included eight IMPs (MMV669810 IC 50 " 1.4 nM; MMV669286"3 nM; MMV672652"3.3 nM; MMV652103"27 nM; MMV674850"28.7 nM; MMV674766"66.4 nM; MMV675615" 72.1 nM; MMV666620"78.9 nM) and four 2-APs (MMV642943 IC 50 " 66 nM; MMV674192"45.2 nM; MMV642944"51.9 nM; MMV643110"71.5 nM) ( Table S1 ). All of these compounds have dual activity between asexual parasites and gametocytes and displayed minimal cross-resistance to the P. falciparum multidrug resistant K1 strain, with resistance indices ,10 (Table S1) . Additionally, the majority of the compounds were highly selective towards P. falciparum asexual parasites (.1000-fold) and late stage gametocytes (.10-fold) compared with mammalian cells (Figure 3b , Table S1 ).
Hit profiling
The activity of selected gametocytocidal compounds was evaluated against late stage gametocytes from currently circulating clinical isolates of southern African origin ( Figure 4 ). These clinical isolates were genotyped and phenotyped for selected drug resistance markers on asexual parasites (Table S2) . 43 The majority of 2-APs and IMPs (but not the DTPs) were comparably active against gametocytes from the clinical isolates and the P. falciparum NF54 reference strain, with the highest activity maintained even in isolates with resistant phenotypes (e.g. JZA 20 and TD_01, both antifolate resistant). MMV642944 and MMV642942 were consistently more active against the clinical isolates compared with the NF54 reference strain. Collectively, this indicates activity towards contemporary clinical isolates of geographical relevance.
The parasitological properties of the 34 compounds with late stage IC 50 s ,1 lM (from Figure 5a ) were additionally evaluated on both early (.90% stage I-III; EG) and late (.95% stage IV/V; LG) stage gametocytes ( Figure S1 and S2). Within the 2-APs, the majority (88%) were significantly more active (P , 0.005, n " 3) towards late stage gametocytes ( Figure 5a , Table S1), as was true for the two drug candidates MMV390048 (EG IC 50 " 214.6 nM; Potent gametocytocidal kinase inhibitors against malaria
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LG IC 50 "140.3 nM) and MMV642943 (EG IC 50 " 134 nM; LG IC 50 " 66 nM). 29, 30 Within the IMPs, the most active compounds showed comparable activity (,2-fold difference) for both early and late stage gametocytes (MMV669810 and MMV669286).
The stage-specific gametocytocidal activity of selected hits from all three series was confirmed via additional evaluation of their speed of action over 24, 48 or 72 h ( Figure 5b ) using each compound at 1 % IC 50 van der Watt et al.
MMV642943. This ability translated directly into blocking transmission to mosquitoes, as evident from a significant reduction in oocyst density for both MMV390048 21 as well as MMV642943 (99% reduction in oocysts, Figure 5c ). MMV642943 resulted in 93% block in transmission (Figure 5c ) with an IC 50 of 96 nM in SMFA ( Figure  5d ) compared with an IC 50 of 111 nM for MMV390048. 21 The IMPs also displayed equipotent activity against stage IV and V gametocytes with MV669810 at 1.4 nM versus 1.2 nM, respectively. This confirms that these compounds are able to target and kill mature, transmissible gametocytes.
Physicochemical space extraction for dual activity
Subsequent preliminary structure-activity relationships (SAR) between and within the three series were inferred by performing chemical feature extraction and biological activity association. Intra-series delineation of the hit compounds was subsequently performed ( Figure 6 ), with very little inter-series overlap observed ( Figure S3a ). Within the DTP series, the thienylpyrimidine backbone was an active representative. The methylation at position R 2 and the phenyl fragment at R 1 , which were previously shown to be required for potent in vitro asexual activity, 22 were confirmed here to be important for the gametocytocidal activity of this chemotype, which was enhanced with lipophilic groups at the phenyl ring para-position.
Dual active compounds within the 2-AP series polarized into two clusters based on chemical similarity. The first cluster contained 3,5-diaryl-2-AP MMV390048 (and its 2-aminopyrazine derivatives, MMV642944 and MMV643110) and the hits MMV642942 and MMV675081, with both asexual 21 and gametocytocidal activity. . These compounds had lower predictive hydrophilicities (cLogP .3) with associated .10-fold activity loss against early stage gametocytes.
Within the IMPs, a homogeneous association was observed between compound activities and chemical features. Similar to the 2-APs, para-and meta-phenyl substitutions at positions 3 and 6, respectively, of the imidazopyridazine core were essential for in vitro asexual 23 and gametocytocidal activity. The R 2 cyclopropylsulfone and R 1 methylsulfonyl improved overall activity of the series. The nitrogen at position 5 of the imidazopyridazine core further enhanced the activity of these compounds to ,10 nM and was particularly important for late stage gametocyte activity, but dependent on the R 2 cyclopropylsulfone.
Functional evaluation of dual active kinase inhibitors
To understand the functional consequence of inhibiting lipid kinases in the parasite, we used global gene expression analysis to evaluate the response of both asexual parasites and gametocytes following inhibition with the PfPI4K inhibitors MMV390048 and MMV642943. An appreciable and tractable drug-specific effect was observed on asexual parasite transcriptomes when treated for 48 h, with 15%-29% of the transcriptome differentially affected [log 2 fold-change MMV672965  MMV668308  MMV669340  MMV667613  MMV672639  MMV667482  MMV668436  MMV670771  MMV668434  MMV670997  MMV666632  MMV390394  MMV674578  MMV674944  MMV674579  MMV670393  MMV674333  MMV034136  MMV674796  MMV390535  MMV668808  MMV668809  MMV672643  MMV670401  MMV668807  MMV670402  MMV394902  MMV674594  MMV670930  MMV642990  MMV642941  MMV643110  MMV675081  MMV666810  MMV642942  MMV673927  MMV674192  MMV390048  MMV668648  MMV642944  MMV668647  MMV642943  MMV639846  MMV674326  MMV670815  MMV672653  MMV652459  MMV652454  MMV670656  MMV665078  MMV670225  MMV666812  MMV674132  MMV675704  MMV669289  MMV672925  MMV670654  MMV674766  MMV675615  MMV666620  MMV652103  MMV669286  MMV674850 Potent gametocytocidal kinase inhibitors against malaria JAC thresholds at 0.5 and #0.5, refer to Gene Expression Omnibus (GEO) number in Materials and methods)]. However, a detectable transcriptional response was not observed at 24 h, which confirms the described moderately slow action of these compounds, with a 24 h lag period.
29 MMV390048-and MMV642943-treated asexual parasites responded nearly identically (Pearson correlation coefficient of 0.96, Figure 7a ). The resultant transcriptional profiles were unique and did not show close association with other antimalarials (Figure 7b) . 44 An enrichment map of the biological processes affected due to MMV390048 or MMV642943 treatment using moderately stringent statistical significance [P , 0.05, false discovery rate (FDR) ,0.1%] included 47 gene sets overrepresented after treatment (Figure 7c) . A variety of different processes were affected as expected after inhibition of proteins involved in phosphatidyl-inositol 4-phosphate (PI4P) synthesis, which has pleiotropic functions involved in intracellular signalling and membrane maintenance. Protein phosphorylation, host cell invasion and intracellular signalling/transport were three particularly strongly affected communities, with multiple members within the nodes showing decreased gene expression after treatment, except for intracellular transport processes that showed increased abundance after treatment (Figure 7c) . Moreover, processes like macromolecular synthesis, protein degradation, protein folding and translocation were severely affected in the treated populations, linked to PfPI4K inhibition. The transcriptional fingerprint for late stage gametocytes displayed similarly affected different biological processes including decreased macromolecular synthesis, lipid synthesis, gene expression and host cell invasion. However, life cycle differences between asexual parasites and gametocytes were evident, as a reduction in protein degradation observed in asexual parasites was not enriched in gametocytes, which do not digest haemoglobin. This implies some divergence in the effect of inhibiting PfPI4K in different life cycle stages. van der Watt et al.
Discussion
Dual active compounds are primary starting points for the generation of antimalarials that are able to treat clinical symptoms and are useful to eliminate malaria. 18 To our knowledge, this study provides the most in-depth evaluation of the lipid kinase inhibitor space for gametocytocidal activity and identifies compounds useful as starting points for development of dual active antimalarials. Additionally, the potent activities observed against late stage gametocytes entice strategies prioritizing gametocyte-only activities as part of the newly defined target candidate profiles. 19, 45 Our data indicate that, although some potential ion-channel modulators show potency against asexual blood stage parasites and gametocytes (e.g. PfATP4 inhibitors), 14, 46 those tested here are generally poor inhibitors of gametocytogenesis. By contrast, compounds selected for their kinase inhibitor chemical background yielded very active gametocytocidal compounds, whilst additionally maintaining their asexual activity. A 2-to 10-fold higher hit identification rate for the compounds tested here, compared with those typically seen by screening diversity-oriented libraries 9, 11, 14, 15, 39, 47, 48 supports the chemical signature for kinase inhibition previously alluded to as gametocytocidal. 14, 41 A total of 34 compounds were identified with submicromolar activity against late stage gametocytes, of which 12 were potent at ,100 nM. Cross-validation of these hits on independent assay platforms and the presence of high selectivity towards the parasite provide confidence to the potency and usefulness of these hit compounds.
Gametocyte stage-specificity and speed of action of such potential transmission-blocking active compounds importantly confirmed that 87% of the hits (,100 nM activity) identified on stage IV/V populations maintained their inhibition against mature stage V gametocytes. The majority of the compounds acted after a 24 h lag period on various stages of gametocytes, similarly to the clinical candidate MMV390048 29 and this effective time frame is sufficient to result in transmission-blocking activity evident for the lead drug candidates (MMV390048 29 and MMV642943 reported here). The luciferase assay on late stage gametocytes therefore has some predictive nature for transmission-blocking activity, confirming previous reports. 49 A subset of compounds preferentially targeted late stage gametocytes, similarly to what has been observed during other screens, 14 raising questions as to the enhanced permeability of late stage gametocytes with a ghostlike erythrocyte and expression of perforin-like proteins. 50 These compounds were characterized as having sulfone/sulfoxide moieties with associated potential membrane permeability limitations in the 2-AP series, but not for the IMPs. This implies that predictive hydrophilicity is not a general indicator of differential activity of compounds against different gametocyte stages. The different stage-specific preferences between compounds within the IMPs and 2-APs may indicate a propensity to target multiple members of structurally related parasite kinases whilst maintaining sufficient selectivity from human kinase inhibition. 16 This scenario may indeed be preferred to inhibitors targeting single kinases that may be more prone to resistance development 51 as has been observed for IMPs that target multiple kinases depending on the different parasite stages during asexual schizogony (e.g. Ca 2! -dependent protein kinase 1 52 and protein kinase G
53
). This late stage gametocyte preference provides appealing starting points from a transmission-blocking perspective for target candidate profile (TCP)-5 strategies. 19 Indeed, development of these as gametocyte-only compounds would require new pharmacokinetic (PK) models, independent of constraints that would be associated with PK modelling of dual active antimalarials.
Several kinases that are associated with gametocytes/gametes 51 are clearly druggable, 54 including lipid kinases like PfPI3K and PfPI4K, particularly in late stage gametocytes. 14, 15, 55 Chemogenomic fingerprinting of MMV390048 and MMV642943 revealed clearly differentiated global effects between asexual parasites and gametocytes, as proteolysis required for haemoglobin digestion in asexual parasites is not observed as affected in In all instances, P. falciparum NF54 was included as drug-susceptible reference strain and MB (5 lM) and DHA (100 lM) as reference drug controls. Results are coloured according to classes as in Table S2 . Data are representative of at least triplicate experiments + SEM; a single biological repeat was performed for SB_07. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Potent gametocytocidal kinase inhibitors against malaria JAC gametocytes. Moreover, shared processes required for cytokinesis 55 are observed resulting in dysregulation of invasion processes during schizogony and in late stage gametocytes in preparation for egress during gametogenesis. Although the transcriptome of gametocytes differs from that of asexual parasites, 56 the altered intracellular distribution of PI4P after PfPI4K inhibition 55 does affect processes in gametocytes (e.g. DNA replication, cytokinesis and chromatin condensation for gamete formation) that rely on PI signalling and lipid transport. This is driven by phospholipase C (PLC)-mediated 57 production of inositol triphosphate (IP3) from van der Watt et al.
phosphatidylinositol-4, 5-bisphosphate (PIP2), 58 which can result in Ca 2! -mediated activation of CDPK4 and Map-2, 59 that drives processes such as cytokinesis. 51, 60 PfPI4K thus initiates a signalling hub involved in a number of core parasite processes during various stages of development.
The potent activity of the 2-APs and IMPs against gametocytes expands the susceptibility profile of these chemotypes, potentially targeting lipid kinases in various stages of malaria parasites. The hit compounds reported here are enticing starting points for the development of dual active antimalarial compounds or compounds targeting only gametocytes in transmission-blocking strategies. 
